ERBB2 and breast carcinoma: In another clinical study involving HER2-negative breast cancer patients, receiving combinational chemotherapy including Dox, reported no apparent changes in LVEF and B-type natriuretic peptide between the placebo group and patients that had been treated co-treated with carvedilol (67).